,BIL-1β

Nicole J Toney1,2, Lynn M Opdenaker1, Lisa Frerichs1

  • 1Cawley Center for Translational Cancer Research, Helen F. Graham Cancer Center and Research Institute Christiana Care Health Services, Inc., 4701 Ogletown Stanton Rd Suite 4300, Newark, DE, 19713, USA.

Scientific reports
|January 17, 2025
PubMed
概括

在三阴性乳腺癌 (TNBC) 中,瘤透的B细胞通过NFκB信号传递来增加Interleukin-1β (IL-1β),从而促进侵袭和迁移. IL-1 抑制剂可能为早期和侵入性TNBC提供新的治疗选择.